Simplex Trading’s Takeda Pharmaceutical TAK Stock Holding History

Simplex Trading’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$95.3K	Buy	+5,146	New	+$90.3K	﹤0.01%	5139
2021 Q4	–	Sell	-28,449	Closed	-$399K	–	11399
2021 Q3	$480K	Sell	28,449 -3,343	-11%	-$56.1K	﹤0.01%	4164
2021 Q2	$535K	Buy	31,792 +14,767	+87%	+$251K	﹤0.01%	4051
2021 Q1	$310K	Buy	17,025 +14,425	+555%	+$260K	﹤0.01%	4105
2020 Q4	$47K	Sell	2,600 -2,000	-43%	-$35.1K	﹤0.01%	6258
2020 Q3	$82K	Hold	4,600	–	–	﹤0.01%	5115
2020 Q2	$82K	Sell	4,600 -10,148	-69%	-$182K	﹤0.01%	5008
2020 Q1	$223K	Buy	+14,748	New	+$267K	﹤0.01%	3467
2019 Q4	–	Sell	-2,166	Closed	-$41.4K	–	7951
2019 Q3	$0	Buy	+2,166	New	+$37.5K	﹤0.01%	7872

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's TAK Position: Q1 2026 in Review

Simplex Trading opened a new position in Takeda Pharmaceutical (TAK) in Q1 2026: 5,146 shares worth $95.3K. The stake represents ﹤0.01% of the portfolio and ranks #5139 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TAK as recently as Q3 2021.

Simplex Trading first reported a position in TAK in Q3 2019 and has held it in 9 quarters since. The position peaked at $535K in Q2 2021. 359 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Simplex Trading held 5,146 shares of Takeda Pharmaceutical worth $95.3K as of Q1 2026.
Takeda Pharmaceutical was a new Simplex Trading position in Q1 2026.
Takeda Pharmaceutical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5139 holding.
Simplex Trading first reported a position in Takeda Pharmaceutical in Q3 2019 and has held it in 9 quarters since.
Simplex Trading's Takeda Pharmaceutical position peaked at $535K in Q2 2021.
359 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.